Impact of pretransplant comorbidities on alemtuzumab-based reduced-intensity conditioning allogeneic hematopoietic SCT for patients with high-risk myelodysplastic syndrome and AML.

PubWeight™: 1.07‹?› | Rank: Top 10%

🔗 View Article (PMID 19767782)

Published in Bone Marrow Transplant on September 21, 2009

Authors

Z Y Lim1, W Ingram, R Brand, A Ho, M Kenyon, S Devereux, J Marsh, G J Mufti, A Pagliuca

Author Affiliations

1: Department of Haematological Medicine, King's College London and King's College Hospital NHS Foundation Trust, London, UK.

Articles citing this

Impact of donor source on hematopoietic cell transplantation outcomes for patients with myelodysplastic syndromes (MDS). Blood (2013) 1.71

How I assess comorbidities before hematopoietic cell transplantation. Blood (2013) 1.52

Who is fit for allogeneic transplantation? Blood (2010) 1.11

Reduced-intensity conditioned allogeneic SCT in adults with AML. Bone Marrow Transplant (2015) 0.96

Prospective Validation of the Predictive Power of the Hematopoietic Cell Transplantation Comorbidity Index: A Center for International Blood and Marrow Transplant Research Study. Biol Blood Marrow Transplant (2015) 0.93

Outcomes of stem cell transplant patients with acute respiratory failure requiring mechanical ventilation in the United States. Bone Marrow Transplant (2014) 0.91

Comorbidity burden in patients with chronic GVHD. Bone Marrow Transplant (2013) 0.86

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis. Blood (2016) 0.84

Risk assessment before allogeneic hematopoietic cell transplantation for older adults with acute myeloid leukemia. Expert Rev Hematol (2013) 0.82

Influence of age on outcome after allogeneic hematopoietic cell transplantation: a single center study in patients aged ⩾60. Bone Marrow Transplant (2015) 0.80

Assessing the Influence of Different Comorbidities Indexes on the Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in a Developing Country. PLoS One (2015) 0.78

High-throughput mutational screening adds clinically important information in myelodysplastic syndromes and secondary or therapy-related acute myeloid leukemia. Haematologica (2015) 0.78

Up-to-date tools for risk assessment before allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2016) 0.75

Impact of pre-transplant co-morbidities on outcome after alemtuzumab-based reduced intensity conditioning allo-SCT in elderly patients: a British Society of Blood and Marrow Transplantation study. Bone Marrow Transplant (2014) 0.75

Articles by these authors

In vivo protein transduction: delivery of a biologically active protein into the mouse. Science (1999) 10.70

TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev (1999) 6.93

High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol (1998) 6.38

Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA (2000) 5.49

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27Kip1 induces cell migration. Nat Med (1998) 4.69

Processing mechanisms in the biosynthesis of proteins. Ann N Y Acad Sci (1980) 4.40

ICOS is essential for effective T-helper-cell responses. Nature (2001) 4.01

For debate: pet birds as an independent risk factor for lung cancer. BMJ (1988) 3.89

Analysis of the synovial cell infiltrate in early rheumatoid synovial tissue in relation to local disease activity. Arthritis Rheum (1997) 3.80

Digital indocyanine green videoangiography of central serous chorioretinopathy. Arch Ophthalmol (1994) 3.44

Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA (1998) 3.32

Replication-defective vector based on a chimpanzee adenovirus. J Virol (2001) 2.86

Evaluation of the Applied Biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA. FEMS Immunol Med Microbiol (2000) 2.80

Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science (1992) 2.60

Neonatal mortality risk in relation to gestational age and birthweight. Results of a national survey of preterm and very-low-birthweight infants in the Netherlands. Lancet (1986) 2.44

Impairments, disabilities, and handicaps of very preterm and very-low-birthweight infants at five years of age. The Collaborative Project on Preterm and Small for Gestational Age Infants (POPS) in The Netherlands. Lancet (1991) 2.41

Morbidity of very low birthweight infants at corrected age of two years in a geographically defined population. Report from Project on Preterm and Small for gestational age infants in The Netherlands. Lancet (1989) 2.35

Hyperbilirubinemia in preterm infants and neurodevelopmental outcome at 2 years of age: results of a national collaborative survey. Pediatrics (1989) 2.34

The PI3 kinase, p38 SAP kinase, and NF-kappaB signal transduction pathways are involved in the survival and maturation of lipopolysaccharide-stimulated human monocyte-derived dendritic cells. Blood (2000) 2.32

HTLV-I screening in Britain. BMJ (1995) 2.25

Hospitalised adult patients with Suspected 2009 H1N1 Infection at Regional Infectious Diseases Units in Scotland--most had alternative final diagnoses. J Infect (2009) 2.24

Brca2 is required for embryonic cellular proliferation in the mouse. Genes Dev (1997) 2.20

Myelofibrosis in primary myelodysplastic syndromes: a clinico-morphological study of 10 cases. Br J Haematol (1989) 2.10

Condom use and first-time urinary tract infection. Epidemiology (1997) 2.08

Hypophosphatemic rickets with hypocalciuria following long-term treatment with aluminum-containing antacid. Bone (1991) 2.06

[More cot deaths in child care settings than during the same hours at home: 10-year statistics]. Ned Tijdschr Geneeskd (2008) 1.98

The EBMT activity survey: 1990-2010. Bone Marrow Transplant (2012) 1.96

In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93

Colorectal carcinomas in mice lacking the catalytic subunit of PI(3)Kgamma. Nature (2000) 1.93

Wessex cardiac surgery follow-up survey: the quality of life after operation. Thorax (1978) 1.93

Mechanical properties of vesicles. II. A model for osmotic swelling and lysis. Biophys J (1993) 1.89

Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant (2005) 1.86

Chemical synthesis and expression of a cassette adapted ubiquitin gene. J Biol Chem (1987) 1.84

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time. Bone Marrow Transplant (2005) 1.79

CDKN2B methylation status and isolated chromosome 7 abnormalities predict responses to treatment with 5-azacytidine. Leukemia (2007) 1.79

Creating a national service for the diagnosis of meningococcal disease by polymerase chain reaction. Commun Dis Public Health (1998) 1.79

Differential regulation of retinoblastoma tumor suppressor protein by G(1) cyclin-dependent kinase complexes in vivo. Mol Cell Biol (2001) 1.78

GLQ223: an inhibitor of human immunodeficiency virus replication in acutely and chronically infected cells of lymphocyte and mononuclear phagocyte lineage. Proc Natl Acad Sci U S A (1989) 1.73

Development of antibodies to unprotected glycosylation sites on recombinant human GM-CSF. Lancet (1990) 1.71

CONCOR, an initiative towards a national registry and DNA-bank of patients with congenital heart disease in the Netherlands: rationale, design, and first results. Eur J Epidemiol (2005) 1.70

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis. Leukemia (2005) 1.70

Elevated insulin receptor content in human breast cancer. J Clin Invest (1990) 1.70

Survivorship analysis in total condylar knee arthroplasty. A statistical review. J Bone Joint Surg Am (1992) 1.69

Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant (2006) 1.67

Bone marrow transplantation (BMT) versus immunosuppression for the treatment of severe aplastic anaemia (SAA): a report of the EBMT SAA working party. Br J Haematol (1988) 1.66

Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party. Ann Intern Med (1999) 1.65

Chronic dialysis in patients with multiple myeloma and renal failure: a worthwhile treatment. Q J Med (1989) 1.65

Meningococcal bacterial DNA load at presentation correlates with disease severity. Arch Dis Child (2002) 1.64

Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction. Clin Chem (1999) 1.62

Does training on an anaesthesia simulator lead to improvement in performance? Br J Anaesth (1994) 1.61

Repression of transcriptional activity at a distance by the evolutionarily conserved KRAB domain present in a subfamily of zinc finger proteins. Nucleic Acids Res (1994) 1.60

Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60

The prevalence of the activating JAK2 tyrosine kinase mutation in chronic porto-splenomesenteric venous thrombosis. Aliment Pharmacol Ther (2010) 1.60

Collagen-induced arthritis in TNF receptor-1-deficient mice: TNF receptor-2 can modulate arthritis in the absence of TNF receptor-1. Clin Immunol (2001) 1.59

Effect of omega-3 fatty acids on growth of a rat mammary tumor. J Natl Cancer Inst (1984) 1.59

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience. Semin Hematol (2000) 1.59

Myelodysplastic syndromes: a scoring system with prognostic significance. Br J Haematol (1985) 1.57

Biological methods for cell-cycle synchronization of mammalian cells. Biotechniques (2001) 1.57

Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group. Leukemia (2012) 1.57

Predictable individual differences in the initiation of cocaine self-administration by rats under extended-access conditions are dose-dependent. Psychopharmacology (Berl) (2001) 1.53

Clonal gammopathies following alemtuzumab-based reduced intensity conditioning haematopoietic stem cell transplantation: association with chronic graft-versus-host disease and improved overall survival. Bone Marrow Transplant (2007) 1.53

The prognosis following acute primary glenohumeral dislocation. J Bone Joint Surg Br (2004) 1.51

Hyperbilirubinemia in low birth weight infants and outcome at 5 years of age. Pediatrics (1992) 1.50

Glenohumeral osteoarthrosis after Putti-Platt repair. J Shoulder Elbow Surg (1999) 1.49

Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience. J Pediatr Gastroenterol Nutr (2008) 1.48

Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant (2007) 1.47

Further comments on cancer of the uterine cervix, smoking, and herpesvirus infection. Am J Epidemiol (1984) 1.47

Prevalence of sleep-disordered breathing in diastolic heart failure. Chest (1997) 1.47

Outcome for children treated with fetal intravascular transfusions because of severe blood group antagonism. J Pediatr (1997) 1.47

The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood (2000) 1.46

Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome. Bone Marrow Transplant (2002) 1.46

Swimming speed distributions of bull spermatozoa as determined by quasi-elastic light scattering. Biophys J (1978) 1.46

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells. J Exp Med (1999) 1.44

Utopia documents: linking scholarly literature with research data. Bioinformatics (2010) 1.43

Immunological abnormalities in myelodysplastic syndromes. II. Coexistent lymphoid or plasma cell neoplasms: a report of 20 cases unrelated to chemotherapy. Br J Haematol (1986) 1.42

Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41

Hyperinfection with strongyloides after treatment for adult T cell leukaemia-lymphoma in an African immigrant. BMJ (1988) 1.41

Granulocyte transfusion: a review. Vox Sang (2001) 1.41

Mortality in very preterm and very low birth weight infants according to place of birth and level of care: results of a national collaborative survey of preterm and very low birth weight infants in The Netherlands. Pediatrics (1988) 1.40

Vision screening of school age children in Missouri. J Am Optom Assoc (1989) 1.40

[Postoperative pain control in The Netherlands]. Ned Tijdschr Geneeskd (1994) 1.39

Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7  TeV. Phys Rev Lett (2011) 1.39

Randomised clinical trial on the effect of the Dutch obstetric peer review system. Eur J Obstet Gynecol Reprod Biol (2002) 1.39

Can patients predict which consultations can be dealt with by telephone? Br J Gen Pract (1998) 1.39

A white paper: the product of a pancreas cancer think tank. Cancer Res (2001) 1.39

Alemtuzumab based reduced intensity conditioning allogeneic haematopoietic stem cell transplantation for myelofibrosis. Leuk Res (2011) 1.38